B-Cell-Activating Factor Contributes to Elevation of the Content of Regulatory B Cells in Neonatal Sepsis.


Journal

Bulletin of experimental biology and medicine
ISSN: 1573-8221
Titre abrégé: Bull Exp Biol Med
Pays: United States
ID NLM: 0372557

Informations de publication

Date de publication:
May 2023
Historique:
received: 02 06 2022
medline: 28 6 2023
pubmed: 20 6 2023
entrez: 20 6 2023
Statut: ppublish

Résumé

We studied the role of B cell-activating factor (BAFF) in PI3K/AKT/mTOR signaling pathway in promoting proliferation and maintaining survival of regulatory B lymphocytes (Breg) in newborns with sepsis. The peripheral blood samples were collected from preterm neonates (n=40) diagnosed with sepsis on the day of diagnosis and on days 7, 14, and 21 after diagnosis, as well as from the matched preterm neonates without sepsis (n=40; control group). The peripheral blood mononuclear cells and B cells were isolated, cultured, and stimulated with LPS and immunostimulant CpG-oligodeoxynucleotide (CpG-ODN). Proliferation and differentiation of B-cells into CD19

Identifiants

pubmed: 37338768
doi: 10.1007/s10517-023-05814-1
pii: 10.1007/s10517-023-05814-1
doi:

Substances chimiques

Proto-Oncogene Proteins c-akt EC 2.7.11.1
Phosphatidylinositol 3-Kinases EC 2.7.1.-
Lipopolysaccharides 0
TOR Serine-Threonine Kinases EC 2.7.11.1
Interleukin-4 207137-56-2
Antigens, CD19 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

72-77

Informations de copyright

© 2023. Springer Science+Business Media, LLC, part of Springer Nature.

Références

Procianoy RS, Silveira RC. The challenges of neonatal sepsis management. J. Pediatr. (Rio J). 2020;96 Suppl 1(Suppl 1):80-86. doi: https://doi.org/10.1016/j.jped.2019.10.004
Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity. 2015;42(4):607-612. doi: https://doi.org/10.1016/j.immuni.2015.04.005
doi: 10.1016/j.immuni.2015.04.005 pubmed: 25902480
Liu Y, Cheng LS, Wu SD, Wang SQ, Li L, She WM, Li J, Wang JY, Jiang W. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection. Clin. Sci. (Lond). 2016;130(11):907-919. doi: https://doi.org/10.1042/CS20160069
doi: 10.1042/CS20160069 pubmed: 26980345
Dambuza IM, He C, Choi JK, Yu CR, Wang R, Mattapallil MJ, Wingfield PT, Caspi RR, Egwuagu CE. IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease. Nat. Commun. 2017;8(1):719. doi: https://doi.org/10.1038/s41467-017-00838-4
doi: 10.1038/s41467-017-00838-4 pubmed: 28959012 pmcid: 5620058
Sarvaria A, Basar R, Mehta RS, Shaim H, Muftuoglu M, Khoder A, Sekine T, Gokdemir E, Kondo K, Marin D, Daher M, Alousi AM, Alsuliman A, Liu E, Oran B, Olson A, Jones RB, Popat U, Hosing C, Champlin R, Shpall EJ, Rezvani K. IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation. Blood. 2016;128(10):1346-1361. doi: https://doi.org/10.1182/blood-2016-01-695122
doi: 10.1182/blood-2016-01-695122 pubmed: 27439912 pmcid: 5016705
Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, Isenberg DA, Mauri C. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med. 2013;5(173):173ra23. doi: https://doi.org/10.1126/scitranslmed.3005407
de Masson A, Bouaziz JD, Le Buanec H, Robin M, O’Meara A, Parquet N, Rybojad M, Hau E, Monfort JB, Branchtein M, Michonneau D, Dessirier V, Sicre de Fontbrune F, Bergeron A, Itzykson R, Dhédin N, Bengoufa D, Peffault de Latour R, Xhaard A, Bagot M, Bensussan A, Socié G. CD24(hi)CD27
Pan X, Ji Z, Xue J. Percentage of Peripheral CD19+ CD24hiCD38hi Regulatory B Cells in Neonatal Sepsis Patients and Its Functional Implication. Med. Sci. Monit. 2016;22:2374-2378. doi: https://doi.org/10.12659/msm.895421
doi: 10.12659/msm.895421 pubmed: 27389933 pmcid: 4946390
Li S, Ma F, Hao H, Wang D, Gao Y, Zhou J, Li F, Lin HC, Xiao X, Zeng Q. Marked elevation of circulating CD19+CD38hiCD24hi transitional B cells give protection against neonatal sepsis. Pediatr. Neonatol. 2018;59(3):296-304. doi: https://doi.org/10.1016/j.pedneo.2017.10.005
doi: 10.1016/j.pedneo.2017.10.005 pubmed: 29239829
Shen P, Roch T, Lampropoulou V, O’Connor RA, Stervbo U, Hilgenberg E, Ries S, Dang VD, Jaimes Y, Daridon C, Li R, Jouneau L, Boudinot P, Wilantri S, Sakwa I, Miyazaki Y, Leech MD, McPherson RC, Wirtz S, Neurath M, Hoehlig K, Meinl E, Grützkau A, Grün JR, Horn K, Kühl AA, Dörner T, Bar-Or A, Kaufmann SHE, Anderton SM, Fillatreau S. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014;507:366-370. doi: https://doi.org/10.1038/nature12979
doi: 10.1038/nature12979 pubmed: 24572363 pmcid: 4260166
Baas M, Besançon A, Goncalves T, Valette F, Yagita H, Sawitzki B, Volk HD, Waeckel-Enée E, Rocha B, Chatenoud L, You S. TGFβ-dependent expression of PD-1 and PD-L1 controls CD8(+) T cell anergy in transplant tolerance. Elife. 2016;5:e08133. doi: https://doi.org/10.7554/eLife.08133
Kannel K, Alnek K, Vahter L, Gross-Paju K, Uibo R, Kisand KV. Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome. PLoS One. 2015;10(11):e0143393. doi: https://doi.org/10.1371/journal.pone.0143393
Zhang X, Park CS, Yoon SO, Li L, Hsu YM, Ambrose C, Choi YS. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Int Immunol. 2005;17(6):779-788. doi: https://doi.org/10.1093/intimm/dxh259
doi: 10.1093/intimm/dxh259 pubmed: 15908449
Yang M, Sun L, Wang S, Ko KH, Xu H, Zheng BJ, Cao X, Lu L. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J. Immunol. 2010;184(7):3321-3325. doi: https://doi.org/10.4049/jimmunol.0902551
doi: 10.4049/jimmunol.0902551 pubmed: 20208006
Khan AR, Hams E, Floudas A, Sparwasser T, Weaver CT, Fallon PG. PD-L1hi B cells are critical regulators of humoral immunity. Nat Commun. 2015;6:5997. doi: https://doi.org/10.1038/ncomms6997
doi: 10.1038/ncomms6997 pubmed: 25609381

Auteurs

W Liao (W)

Department of Pediatrics, Dongguan Houjie Hospital, Dongguan, China.

H Xiao (H)

Department of Pediatrics, Dongguan Houjie Hospital, Dongguan, China.

J He (J)

Department of Pediatrics, Dongguan Houjie Hospital, Dongguan, China.

L Huang (L)

Department of Pediatrics, Dongguan Houjie Hospital, Dongguan, China.

Y Liao (Y)

Department of Pediatrics, Dongguan Houjie Hospital, Dongguan, China.

J Qin (J)

Department of Pediatrics, Dongguan Houjie Hospital, Dongguan, China.

Q Yang (Q)

Department of Pediatrics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

F Ma (F)

Department of Pediatrics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

S Li (S)

Department of Pediatrics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. lisit@mail.sysu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH